Showing results (1301-1310 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|July 3, 2007
Risk of diabetic ketoacidosis after exposure to risperidone or olanzapineKrishnan Ramaswamy, Chris M Kozma, Henry NasrallahDrug Safety|July 3, 2007
Prescription-event monitoring: developments in signal detectionGermano FerreiraDrug Safety|April 3, 2009
Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactiveJohn Dormandy, Mondira Bhattacharya, Anne-Ruth van Troostenburg de Bruyn, et al.Drug Safety|October 26, 2022
A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 DiabetesDavid Tak Wai Lui, Tingting Wu, Ivan Chi Ho Au, et al.Drug Safety|September 15, 2022
Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the NetherlandsEsther de Vries, Elisabeth Bakker, Taco B M Monster, et al.Drug Safety|May 1, 1994
A risk-benefit assessment of vigabatrin in the treatment of neurological disordersJ Srinivasan, A RichensDrug Safety|April 1, 1994
Adverse effects and drug interactions of clinical importance with antiviral drugsD J MorrisDrug Safety|April 1, 1994
Risk-benefit assessment of drug treatment to prevent coronary heart disease. Estimating the benefits of risk factor modificationS A Grover, L CoupalDrug Safety|February 1, 1993
Pitfalls and problems of the long term use of neuroleptic drugs in schizophreniaM F Bristow, S R HirschPageof 311